Mackenzie Financial Corp Grows Stock Position in DaVita Inc. (NYSE:DVA)

Key Points

• Mackenzie Financial Corp increased its stake in DaVita Inc. by 87.4% in the first quarter, owning a total of 14,861 shares valued at approximately $2.27 million.
• Analysts have mixed opinions on DaVita's stock, with an average rating of "Hold" and a consensus price target of $167.40.
• DaVita's recent earnings report showed a $2.00 EPS, surpassing expectations, with a revenue increase of 5.0% compared to the same quarter last year.

Mackenzie Financial Corp raised its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 87.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,861 shares of the company's stock after purchasing an additional 6,930 shares during the quarter. Mackenzie Financial Corp's holdings in DaVita were worth $2,273,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. UMB Bank n.a. grew its position in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after buying an additional 76 shares during the last quarter. Copia Wealth Management purchased a new position in shares of DaVita in the 4th quarter worth approximately $30,000. Coppell Advisory Solutions LLC grew its position in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita in the 4th quarter worth approximately $55,000. Finally, GeoWealth Management LLC grew its position in shares of DaVita by 30.6% in the 4th quarter. GeoWealth Management LLC now owns 525 shares of the company's stock worth $79,000 after buying an additional 123 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DVA. Truist Financial dropped their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research report on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $167.40.

Insiders Place Their Bets

In related news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider directly owned 26,038 shares in the company, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.00% of the stock is currently owned by company insiders.

DaVita Stock Up 1.0%

DVA stock traded up $1.46 during midday trading on Tuesday, reaching $140.98. 1,224,624 shares of the company were exchanged, compared to its average volume of 716,086. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. DaVita Inc. has a 1-year low of $131.76 and a 1-year high of $179.60. The stock's 50-day simple moving average is $140.47 and its 200 day simple moving average is $147.52. The company has a market cap of $10.64 billion, a price-to-earnings ratio of 13.97, a price-to-earnings-growth ratio of 0.96 and a beta of 1.09.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The company's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.00 EPS. On average, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.